SAMANTHA BEREIT: Open Payments
NPI 1255878740 · OLATHE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 30 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 7 | $138 |
| Axsome Therapeutics, Inc. | 5 | $93 |
| Noven Therapeutics, LLC | 3 | $58 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Corium, LLC | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Bausch Health US, LLC | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
Products named: Qelbree, Auvelity, Xelstrym, Azstarys, FANAPT, APLENZIN, INGREZZA, VRAYLAR.
Industry payments across KS — which companies pay providers there.
